Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Adma Biologics (ADMA)

5.38 0.2 (3.86%)

05-22 16:00

Open:

5.22

Pre. Close:

5.18

High:

5.58

Low:

5.135

Volume:

232,250

Market Cap:

198M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

5.584 - 5.611

5.611 - 5.635

Low:

5.076 - 5.105

5.105 - 5.132

Close:

5.331 - 5.378

5.378 - 5.422

Technical analysis  (as of: 2018-05-22 4:36:23 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 6.66     One year: 7.77

Support:

Support1: 4.96    Support2: 4.50

Resistance:

Resistance1: 5.70    Resistance2: 6.66

Pivot:

5.05

Moving Averages:

MA(5): 5.31     MA(20): 5.03

MA(100): 4.34     MA(250): 3.62

MACD:

MACD(12,26): 0.12     Signal(12,26,9): 0.09

%K %D:

%K(14,3): 69.50     %D(3): 69.78

RSI:

RSI(14): 59.39

52-Week:

High: 5.699  Low: 2.01  Change(%): 51.1

Average Vol(K):

3-Month: 13391  10-Days 26803

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ADMA has closed below upper band by 17.4%. Bollinger Bands are 22% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-05-16T08:42:40-04:00
ADMA Biologics granted U.S. Patent for treating respiratory infections

2018-05-14T17:16:29-04:00
ADMA Biologics misses by $0.08, misses on revenue

2018-05-14T14:08:26-04:00
ADMA Bio retires 8.6M shares of stock issued to Biotest; shares up 10%

2018-04-05T12:11:42-04:00
Institutional Top Ideas Series: Broadfin Capital

2018-03-23T13:07:49-04:00
Institutional Top Ideas Series: Consonance Capital

2018-03-06T07:36:21-05:00
ADMA Biologics: Almost Ready To Run Between The Toes Of Giants

2018-03-05T07:11:59-05:00
ADMA Biologics reports FY results

2018-03-02T11:03:10-05:00
Key events next week - healthcare

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

45.32

Shares Float (M)

45.16

% Held by Insiders

0.30

% Held by Institutions

81.50

Shares Short (K)

193

Shares Short Prior Month (K)

110

Stock Financials

EPS

-0.710

EPS Est. Current Year

-1.740

EPS Est. Next Year

-1.080

EPS Est. Next Quarter

-0.370

Forward EPS

-0.390

Book Value (p.s.)

5.400

PEG Ratio

Profit Margin

Operating Margin

-147.91

Return on Assets (ttm)

-66.4

Return on Equity (ttm)

-243.9

Qtrly Rev. Growth

260.7

Gross Profit (p.s.)

-0.143

Sales Per Share

EBITDA (p.s.)

-0.607

Qtrly Earnings Growth

Operating Cash Flow (M)

-37.27

Levered Free Cash Flow (M)

-30.71

atoplab.com

Valuation

P/E

-7.58

P/E Growth Ratio

0.04

P/BV

P/S

199603440.00

P/CF

-6.54

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.